Yuhan Corporation (000100.KS) stock analysis
In our weekly check, Yuhan Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 7, red flags: 1.
About Yuhan Corporation
Yuhan Corporation is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in South Korea, listed on KSC as 000100.KS.
What our checks show for 000100.KS
Red flags
- Return on capital (ROCE) is only 4.8%.
Warning signs
- Operating cash flow is only 0.7x net profit: part of the reported profit does not arrive as cash.
- Free cash flow is only 0.6% of revenue.
- Free cash flow covers the dividend only 0.3 times.
- The price swings a lot: 42.3% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 59% from a peak. Would you have held through that?
- The stock is still below its previous peak.
- Thinly traded (about 269 thousand shares a day): buying and selling can move the price.
Strengths
- Debt is low: 0.15x equity.
- The net margin rose by 4.3 points over 5 years, to 10.4%.
- The gross margin is 34.3% and has risen by 3.2 points: pricing power is holding.
- Analysts expect earnings per share to grow about 11.4% a year over the next years.
- Earnings per share grew 33.3% a year over the last 3 years.
- Net profit grew 35.6% a year over the last 3 years.
Similar companies
SUNPHARMA.NS · DIVISLAB.NS · 4507.T · TORNTPHARM.NS · 4523.T · LAURUSLABS.NS
Questions
What grade does Yuhan Corporation (000100.KS) have?
In our weekly check, Yuhan Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 7, red flags: 1. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of 000100.KS stock?
This week's biggest flags for Yuhan Corporation: Low return on capital, Profits not backed by cash, Weak free cash flow. In total 8 of 25 checks show a warning or a red flag.
What does Yuhan Corporation do?
Yuhan Corporation is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in South Korea, listed on KSC as 000100.KS.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-10-31
Open the full analysis